Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 148Myelodysplastic Syndromes 116Leukemia 115Precursor Cell Lymphoblastic Leukemia-Lymphoma 95Lymphoma 86Lymphoma, Non-Hodgkin 80Multiple Myeloma 74Hodgkin Disease 68Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Large B-Cell, Diffuse 52Myeloproliferative Disorders 51Congenital Abnormalities 51Leukemia, Myeloid, Chronic-Phase 50Lymphoma, Follicular 47Leukemia, Myeloid, Accelerated Phase 47Neoplasms, Plasma Cell 46Lymphoma, Mantle-Cell 43Leukemia, Myelomonocytic, Chronic 43Burkitt Lymphoma 42Lymphoma, B-Cell, Marginal Zone 41Lymphoma, Large-Cell, Immunoblastic 39Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Blast Crisis 39Primary Myelofibrosis 36Recurrence 33Anemia, Refractory, with Excess of Blasts 33Hematologic Neoplasms 32Myelodysplastic-Myeloproliferative Diseases 31Graft vs Host Disease 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 28

Interventions

fludarabine 2Busulfan 2thymoglobulin 1fludarabine phosphate 1bicalutamide 1Testosterone 1Saline Solution 1Powders 1Nutrition Assessment 1Metformin 1Mesna 1Melphalan 1Influenza Vaccines 1Honey 1Heparin 1Gonadotropin-Releasing Hormone 1Gastric Bypass 1Exercise 1Eating 1Cyclophosphamide 1Clofarabine 1Caloric Restriction 1Antineoplastic Agents 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Metabolic Diseases × Busulfan × Clear all
NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

University of Rochester

Recruiting
30 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡